Press Release: DoseSpot Acquires TreatRx from Bravado Health

DoseSpot has recently acquired TreatRx, Bravado Health’s ePrescribing business, enabling us to expand our capabilities and serve more customers. Their platform, Treat 5 is a standalone solution with no EHR/EMR required. By welcoming Treat, we can create even more powerful and effective ePrescribing solutions.

As DoseSpotters, we are in pursuit of growth, and while this acquisition represents new growth, it is also a testament to our commitment to innovation.

“We’re thrilled to welcome TreatRx to the DoseSpot community. This acquisition represents a significant milestone for us as we continue to invest in and expand our ePrescribing platform. By incorporating Bravado Health’s ePrescribing technology and expertise, we can offer even more value to our current and future customers, helping them to practice safe prescribing, increase practice efficiency, and stay compliant with state and federal mandates.”

Josh Weiner, CEO

Read the full press release here.